|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$49.2M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$20.7M
|
+$3.94M
|
+382,818
|
+19%
|
|
|
3
|
|
$17.3M
|
-$30.4K
|
-2,953
|
-0.1%
|
|
|
4
|
Avidity Partners Management
Dallas,
Texas
|
$16.2M
|
-$269K
|
-26,200
|
-1%
|
|
|
5
|
Vanguard Group
Malvern,
Pennsylvania
|
$15.9M
|
-$595K
|
-57,849
|
-3%
|
|
|
6
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$14.1M
|
+$5.87M
|
+570,729
|
+52%
|
|
|
7
|
|
$13.3M
|
+$2.05M
|
+199,220
|
+14%
|
|
|
8
|
683 Capital Management
New York
|
$12.2M
|
+$11.2M
|
+1,085,000
|
+306%
|
|
|
9
|
Abingworth
London,
United Kingdom
|
$12.1M
|
–
|
–
|
–
|
|
|
10
|
Janus Henderson Group
London,
|
$9.22M
|
-$9.35M
|
-909,230
|
-45%
|
|
|
11
|
Mirae Asset Global Investments
Seoul,
South Korea
|
$6.7M
|
+$925K
|
+89,942
|
New
|
|
|
12
|
Gilder Gagnon Howe & Co
New York
|
$4.69M
|
-$1.93K
|
-188
|
-0%
|
|
|
13
|
GW&K Investment Management
Boston,
Massachusetts
|
$4.17M
|
+$142K
|
+13,808
|
+3%
|
|
|
14
|
StepStone Group
La Jolla,
California
|
$3.56M
|
–
|
–
|
–
|
|
|
15
|
State Street
Boston,
Massachusetts
|
$3.45M
|
+$451K
|
+43,838
|
+12%
|
|
|
16
|
Geode Capital Management
Boston,
Massachusetts
|
$2.93M
|
+$341K
|
+33,119
|
+11%
|
|
|
17
|
Eventide Asset Management
Boston,
Massachusetts
|
$2.84M
|
–
|
–
|
–
|
|
|
18
|
Newtyn Management
New York
|
$2.16M
|
+$2.63M
|
+255,767
|
New
|
|
|
19
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$1.99M
|
–
|
–
|
–
|
|
|
20
|
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
$1.69M
|
-$63.6K
|
-6,184
|
-3%
|
|
|
21
|
MPM BioImpact
Boston,
Massachusetts
|
$1.63M
|
–
|
–
|
–
|
|
|
22
|
Northern Trust
Chicago,
Illinois
|
$1.6M
|
+$114K
|
+11,078
|
+6%
|
|
|
23
|
|
$1.44M
|
-$49.1K
|
-4,775
|
-3%
|
|
|
24
|
UBS O'Connor
Chicago,
Illinois
|
$1.07M
|
+$921K
|
+89,591
|
+239%
|
|
|
25
|
Charles Schwab
San Francisco,
California
|
$1.01M
|
-$65.5K
|
-6,373
|
-5%
|
|
